Immunotherapeutic utility of stimulatory and suppressive oligodeoxynucleotides

Ken J Ishii1, Ihsan Gursel, Mayda Gursel

  • 1Akira Innate Immunity Project, ERATO, Japan Science and Technology Agency, Department of Host Defense, Research Institute for Microbial Diseases, Osaka University, 3-1 Yamada-oka, Osaka 565-0871, Japan.

Current Opinion in Molecular Therapeutics
|June 16, 2004
PubMed

Insights

CpG motifs in bacterial DNA activate immune cells via toll-like receptor 9. Synthetic CpG oligodeoxynucleotides (ODNs) show therapeutic potential but can also trigger autoimmune disease, necessitating careful application.

Area of Science:

  • Immunology
  • Molecular Biology
  • Therapeutics

Background:

  • Bacterial DNA contains CpG motifs that activate immune cells through toll-like receptor 9 (TLR9).
  • Synthetic oligodeoxynucleotides (ODNs) containing CpG motifs mimic bacterial DNA's immunostimulatory effects.
  • Different CpG ODN structures differentially activate human immune cells.

Purpose of the Study:

  • To review the therapeutic potential of CpG ODNs as vaccine adjuvants, anti-allergens, and treatments for diseases.
  • To discuss the dual nature of CpG ODNs, including their potential to exacerbate autoimmune conditions.
  • To explore the role of G-rich suppressive motifs in blocking CpG DNA's immunomodulatory activity.

Main Methods:

  • Review of scientific literature on CpG ODNs and their interaction with TLR9.
  • Analysis of different CpG ODN structures and their immune activation profiles.
  • Discussion of therapeutic applications and potential adverse effects.

Main Results:

  • CpG ODNs can potently stimulate immune responses, including cytokine and immunoglobulin production.
  • Structurally distinct CpG ODNs exhibit differential activation of human immune cells.
  • G-rich DNA motifs can suppress CpG-mediated immune activation.

Conclusions:

  • CpG ODNs hold significant therapeutic promise for various conditions, including cancer and infectious diseases.
  • The immunomodulatory effects of CpG ODNs necessitate careful consideration of potential autoimmune risks.
  • Understanding and manipulating CpG ODN activity, including suppressive motifs, is crucial for safe and effective therapeutic development.

Related Concept Videos

Inhibitors of Viral Protein Synthesis01:30

Inhibitors of Viral Protein Synthesis

Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
Cytotoxic T Cells-mediated Immune Response01:27

Cytotoxic T Cells-mediated Immune Response

Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Antiviral Nucleoside Inhibitors01:22

Antiviral Nucleoside Inhibitors

Antiviral Nucleoside InhibitorsAntiviral nucleoside inhibitors are structural analogs of natural nucleosides that interfere with viral DNA or RNA synthesis. These compounds selectively target viral polymerases due to their resemblance to host nucleosides, thereby disrupting viral genome replication.Mechanism of Acyclovir ActionAcyclovir is a guanosine analog with a three-carbon acyclic side chain. It selectively targets herpes simplex virus type 1 (HSV-1), herpes simplex virus type 2 (HSV-2),...